Quality measures for the care of adult patients with restless legs syndrome

Journal of Clinical Sleep Medicine

Volumn 11, Issue 3, 2015, Pages 293-310

  Trotti, Lynn Marie ^a   Goldstein, Cathy A ^b   Harrod, Christopher G ^c   Koo, Brian B ^d   Sharon, Denise ^e   Zak, Rochelle ^f   Chervin, Ronald D ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c American Academy of Sleep Medicine   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; OPIATE;

APPLICATION SITE REACTION; ARTICLE; CLINICAL PRACTICE; COGNITIVE DEFECT; CONSTIPATION; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG ABUSE; EVIDENCE BASED MEDICINE; FATIGUE; HALLUCINATION; HEADACHE; HUMAN; IMPULSE CONTROL DISORDER; INSOMNIA; IRON STORAGE; META ANALYSIS; MOOD CHANGE; NAUSEA; OUTCOME ASSESSMENT; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTLESS LEGS SYNDROME; SEDATION; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP MEDICINE; SLEEP QUALITY; SOMNOLENCE; SUICIDAL BEHAVIOR; SWELLING; SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT; VOMITING; WEIGHT GAIN; XEROSTOMIA; ADULT; HEALTH CARE QUALITY; SEVERITY OF ILLNESS INDEX; STANDARDS; TREATMENT OUTCOME;

ADULT; HUMANS; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; SLEEP MEDICINE SPECIALTY; TREATMENT OUTCOME;

EID: 84924901859     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.4550     Document Type: Article

References (49)

1. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165:1286-92.
2. Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006;7:545-52.
3. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-5.
4. Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 2006;129:76-80.
5. Lee HB, Hening WA, Allen RP, et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci 2008;20:101-5.
6. Hening WA, Allen RP, Chaudhuri KR, et al. Clinical significance of RLS. Mov Disord 2007;22 Suppl 18:S395-400.
7. Rye DB, Trotti LM. Restless legs syndrome and periodic leg movements of sleep. Neurol Clin 2012;30:1137-66.
8. American Academy of Sleep Medicine. http://www.aasmnet.org/aboutaasm. aspx. 2014.
9. Morgenthaler TI, Aronsky AJ, Carden KA, Chervin RD, Thomas SM, Watson NF. Measurement of quality to improve care in sleep medicine. J Clin Sleep Med 2015;11:279-91.
10. Benes H, Walters AS, Allen RP, Hening WA, Kohnen R. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord 2007;22 Suppl 18:S401-8.
11. Ondo WG. Common comorbidities and differential diagnosis of restless legs syndrome. J Clin Psychiatry 2014;75:e06.
12. Silber MH, Becker PM, Earley C, Garcia-Borreguero D, Ondo WG. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc 2013;88:977-86.
13. Cuellar NG, Hanlon A, Ratcliffe SJ. The relationship with iron and health outcomes in persons with restless legs syndrome. Clin Nurs Res 2011;20:144-61.
14. O'Keeffe ST, Noel J, Lavan JN. Restless legs syndrome in the elderly. Postgrad Med J 1993;69:701-3.
15. Ohayon MM, O'Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev 2012;16:283-95.
16. Curgunlu A, Doventas A, Karadeniz D, et al. Prevalence and characteristics of restless legs syndrome (RLS) in the elderly and the relation of serum ferritin levels with disease severity: hospital-based study from Istanbul, Turkey. Arch Gerontol Geriatr 2012;55:73-6.
17. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep 1998;21:371-7.
18. Frauscher B, Gschliesser V, Brandauer E, et al. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels. Sleep Med 2009;10:611-5.
19. Hogl B, Oertel WH, Stiasny-Kolster K, et al. Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch. BMC Neurol 2010;10:86.
20. Trotti LM, Bhadriraju S, Becker LA. Iron for restless legs syndrome. Cochrane Database Syst Rev 2012;5:CD007834.
21. Silber MH. Sleep-related movement disorders. Continuum. 2013;19:170-84.
22. Aurora RN, Kristo DA, Bista SR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 2012;35:1039-62.
23. Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev 2009;23:95-104.
24. Weinstock LB, Walters AS, Paueksakon P. Restless legs syndrome-theoretical roles of inflammatory and immune mechanisms. Sleep Med Rev 2012;16:341-54.
25. Silber MH, Richardson JW. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clinic Proc 2003;78:52-4.
26. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-32.
27. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004;5:237-46.
28. Garcia-Borreguero D, Kohnen R, Silber MH, et al. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep Med 2013;14:675-84.
29. Garcia-Borreguero D, Larrosa O, de la Llave Y, Granizo JJ, Allen R. Correlation between rating scales and sleep laboratory measurements in restless legs syndrome. Sleep Med 2004;5:561-5.
30. Hogl B, Gschliesser V, Poewe W. Assessing treatment outcome in RLS trials and clinical care: CGI-I, PGI, or VAS? Sleep Med 2013;14:125-6.
31. Trenkwalder C, Kohnen R, Allen RP, et al. Clinical trials in restless legs syndrome-recommendations of the European RLS Study Group (EURLSSG). Mov Disord 2007;22 Suppl 18:S495-504.
32. Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M. Dopamine agonists for restless legs syndrome. Cochrane Database Syst Rev 2011:CD006009.
33. Godau J, Spinnler N, Wevers AK, Trenkwalder C, Berg D. Poor effect of guideline based treatment of restless legs syndrome in clinical practice. J Neurol Neurosurg Psychiatry 2010;81:1390-5.
34. Wilt TJ, MacDonald R, Ouellette J, et al. Treatment for restless legs syndrome. comparative effectiveness review No. 86. AHRQ Publication 2012;12(13).
35. Hornyak M, Scholz H, Kohnen R, Bengel J, Kassubek J, Trenkwalder C. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications. Sleep Med Rev 2014;18:153-64.
36. Garcia-Borreguero D, Ferini-Strambi L, Kohnen R, et al. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol 2012;19:1385-96.
37. Trenkwalder C, Benes H, Grote L, et al. Prolonged release oxycodonenaloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol 2013;12:1141-50.
38. Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004;2:12.
39. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press, 2001.
40. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006;166:565-71.
41. Agency for Healthcare Research and Quality. Treatment for restless legs syndrome: clinician research summary. AHRQ Publication 2013;12:EHC147-3.
42. Bayard S, Langenier MC, Dauvilliers Y. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome. Sleep 2013;36:1501-7.
43. Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 2010;33:81-7.
44. Voon V, Potenza MN, Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol 2007;20:484-92.
45. Evans AH, Butzkueven H. Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis. Mov Disord 2007;22:590-1.
46. Garcia-Borreguero D, Allen RP, Kohnen R, et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 2007;8:520-30.
47. de Oliveira MM, Conti CF, Valbuza JS, de Carvalho LB, do Prado GF. The pharmacological treatment for uremic restless legs syndrome: evidencebased review. Mov Disord 2010;25:1335-42.
48. Picchietti DL, Hensley JG, Bainbridge JL, et al. Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation. Sleep Med Rev 2014 Nov 4. [Epub ahead of print].
49. American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine, 2014.